As of August 28, 2026, CytomX Therapeutics, Inc. (CTMX) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. CytomX Therapeutics, Inc. has a market capitalization of $783.73M, 217.90M shares outstanding, 183 institutional holders tracked. Stored dilution-related fields include 81.6K outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CTMX.
Market Data
Market Cap$783.73M
Shares Outstanding217.90M
Float186.26M
Cash$94.72M
Debt$2.99M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 47.5% shares (2026Q1 vs prior)
183 institutional holders · 222.39M shares
#1
FMR LLC
31.96M shares
#2
PERCEPTIVE ADVISORS LLC
20.20M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
17.47M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest35.11M
Days to Cover11.8
% of Float18.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-03-31
Form 4
INSIDER TRANSACTION
2026-08-03
Form 4
INSIDER TRANSACTION
2026-08-03
Form 4
INSIDER TRANSACTION
2026-07-24
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CTMX Dilution Snapshot
CytomX Therapeutics, Inc. (CTMX) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CTMX: Form 4 on 2026-08-03; Form 4 on 2026-08-03; Form 4 on 2026-07-24.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CTMX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTMX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CTMX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.